Article
Exogenous binding immunoglobulin protein (BiP) enhance immune regulatory phenotype in ex-vivo Mtb infected PBMCs stratified based on QuantiFERON response.
Cytokine - 1 Feb 2025
Motaung Bongani, Snyders Candice, Malherbe Stephanus, Gutschmidt Andrea, van Rensburg Ilana, Loxton Andre G
Abstract excerpt
Even though anti-tuberculosis (TB) treatment is readily available, Mycobacterium tuberculosis (Mtb) infection continues to be a global threat with a high death rate recorded from a single infectious agent. This highlights the significance of developing new strategies to curb the growing Mtb infection cases. Host-directed therapies (HDT) offer a promising approach that includes both drug discovery and drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
